The following trials provide information to treat various types of cancer and infectious disease, both for ongoing and completed clinical trials. For more information on our oncology therapy area please click here or for our infection therapy area please click here.
- collapse A Phase I, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics o fAZD5438 Given Orally, in 2 dosing schedules, in Patients with Advanced Solid Malignancies.
- collapse A Randomised, Open-label, Phase I Study to Determine the Effect of Food on the Pharmacokinetics of Oral AZD8931 Tablets in Healthy Subjects
- collapse Longitudinal, randomized, open and prospective clinical trial to evaluate the efficacy of continuous vs intermittent maximum androgen blockade (CMAB vs IMAB) with gosereline-bicalutamide combination in the treatment of hormonal naïve with metastatic prostate cancer.
- collapse A Compassionate Use Trial With Bicalutamide (CASODEX) 150-mg for Subjects With Prostate Cancer
- collapse Preventing Gynaecomastia using two different Nolvadex doses
- collapse A prospective randomised, open, multicentre, phase III study to assess different durations of anastrozole therapy after 2 to 3 years tamoxifen as adjuvant therapy in postmenopausal women with breast cancer.
- collapse A Prospective,Open-Label Study of Anastrozole in Post-Menopausal Women With Hormone Sensitive Advanced Breast Cancer
- collapse An open, multicentre phase II trial assessing the objective response rate after combination of Arimidex 1mg per os per day and Zoladex 3.6 mg sub cutaneously monthly as first treatment for premenopausal receptor positive advanced or metastatic breast cancer
- collapse Postmenopausal women with early hormone-receptor positive breast cancer/no metastasis>
- collapse A randomised trial to compare the efficacy and safety of Arimidex with Tamoxifen as adjuvant treatment of breast cancer.
